Pharmaceutical News and Articles

Ipsen Voluntarily Withdraws Tazverik (tazemetostat) in Follicular Lymphoma and Epithelioid Sarcoma

PARIS, FRANCE, 09 March 2026 Ipsen (Euronext IPN ADR IPSEY) announced today that it is voluntarily withdrawing Tazverik (tazemetostat) in all indications from a

AbbVie Announces Positive Topline Results from a Phase 1 Multiple Ascending Dose Study of ABBV-295, a Long-Acting Amylin Analog, in Adults

AbbVie (NYSE ABBV) today announced positive topline results1 from the multiple ascending dose (MAD) part of its Phase 1 study evaluating the safety, tolerabilit

Xspray Pharma Re-Submits its FDA Application for Dasynoc

Annual Sunscreen Protection Can Cost as Little as $40 per Year

Using sunscreen can cost as little as 40 a year or as much as 1,400 a year, according to a study published online Feb. 18 in JAMA Dermatology.Maya Mundada, from

Many Seniors Gain Physical, Mental Fitness As They Age, Study Finds

MONDAY, March 9, 2026 People think of aging as a steady decline, with seniors gradually losing their physical abilities and mental agility as the years wear on.

Infant Bath Seats Sold on Amazon Recalled Due To Tipping Hazard

MONDAY, March 9, 2026 Parents are being asked to stop using certain baby bath seats after officials said the products could tip over and put infants at risk for

FDA Vaccine Chief Dr. Vinay Prasad Exiting Role

MONDAY, March 9, 2026 Dr. Vinay Prasad, who leads the U.S. Food and Drug Administration (FDA) division that oversees vaccines and complex medical treatments, is

That Stressful Person in Your Life Might Be Aging You Faster, Study Finds

MONDAY, March 9, 2026 Spending time with someone who constantly causes problems may do more than just ruin your mood. Over time, those stressful relationships c

'Fibermaxxing' Trend Encourages People To Eat More Fiber

MONDAY, March 9, 2026 A growing nutrition trend called fibermaxxing is encouraging people to eat enough fiber each day, and scientists say the attention may be

GLP-1 Receptor Agonist Use Linked to Reduced Risks for Substance Use Disorder

The use of glucagon-like peptide-1 (GLP-1) receptor agonists is associated with reduced risks for developing substance use disorders (SUDs), according to a stud